Skip to Main Content

Paper Details

Contribution of HLA and KIR Alleles to Systemic Sclerosis Susceptibility and Immunological and Clinical Disease Subtypes.
Front Genet
7
2022
ATA, Class I HLA ligands, Class II HLA, HLA, HLA and KIR Alleles, HLA class I ligands, KIR Alleles, KIRs, SSc, Systemic Sclerosis, Systemic sclerosis, activating and inhibitory lymphocyte receptors, anti-topoisomerase, anti-topoisomerase (ATA) positive disease, autoinflammatory, fibrotic condition, lymphocyte, nuclear antigens, patient, topoisomerase-1, topoisomerase-1 derived peptides
Author NameAffiliation
Maureen D MayesUniversity of Texas
Tony J KennaInstitute of Health and Biomedical Innovation, Queensland University of Technology
Matthew A Brown
Matthew A BrownKing's College London
  • 1 - 4

Datasets

Release 1.2